RecruitingNCT07224906

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart


Sponsor

HemoCept Inc.

Enrollment

50 participants

Start Date

Dec 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an observational study in which researchers measure heart function using a thin tube inserted into the right side of the heart (a right heart catheterization, or RHC). The study aims to better understand pressure and blood flow measurements in the heart across a range of cardiac conditions. No experimental treatment is being given — participants are simply having a procedure that was already scheduled. **You may be eligible if...** - You are 18 years or older - You are already scheduled to undergo a right heart catheterization procedure (with or without a left heart procedure done at the same time) - You are willing to sign informed consent **You may NOT be eligible if...** - You are pregnant, breastfeeding, or plan to become pregnant during the study - You are only scheduled for a left heart catheterization (not a right heart procedure) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Boulder Heart

Boulder, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07224906


Related Trials